The Efficacy of Ivermectin in Larger Doses in COVID-19 Treatment
ConditionCOVID
Trial statusRecruiting
Trial phasePhase 2, Phase 3
Trial typeInterventional
Biological sexAll
AgeNot listed
SponsorTanta University
About this trial
Efficacy of Ivermectin in larger doses in COVID-19 treatment
Eligibility criteria
Qualifiers
Patients with covid 19
Disqualifiers
Allergy or side effects to treatment
Trial design
Treatments tested in this trial
- Ivermectin
Treatment groups
300 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov